Lambda Therapeutic Research
Ahmedabad, India· Est.
A global full-service CRO specializing in biosimilar development and clinical trial management across multiple therapeutic areas.
Is this your company? Claim your profile to update info and connect with investors.
Claim profilePrivate Company
Funding information not available
AI Company Overview
A global full-service CRO specializing in biosimilar development and clinical trial management across multiple therapeutic areas.
OncologyHematologyDermatologyNeurosciencePulmonologyInfectious DiseaseCardiovascular & Metabolic DiseasesGastroenterologyNephrologyOphthalmologyMusculoskeletal
Technology Platform
Integrated clinical trial management systems with electronic data capture (EDC) platforms and state-of-the-art analytical laboratories featuring ELISA, ECLIA, IVD, and flow cytometry capabilities.
Opportunities
Growth opportunities include expanding biosimilar development services as patent expirations accelerate, leveraging regulatory expertise in emerging markets, and capitalizing on increased pharmaceutical outsourcing trends.
Risk Factors
Key risks include intense competition from larger global CROs, regulatory changes across multiple jurisdictions, and dependence on pharmaceutical industry R&D spending cycles.
Competitive Landscape
Competes with global CROs like IQVIA, Parexel, and PPD, differentiated by specialized biosimilar expertise, strong regulatory capabilities in emerging markets, and cost-effective operations from its India base.